Integrated Shield premiums are set to increase in September 2024. How does this affect me?

All you need to know about the end of the Integrated Shield premium freeze.

iFAST Insurance Team
iFAST Insurance Team29 Aug 2024 8906 Views

What is Integrated Shield Plan?

All Singaporeans and Permanent Residents (PRs) are automatically enrolled into MediShield Life, a basic health insurance plan that covers for the cost of treatment in public hospital at B2/C ward types. If you are happy to only receive treatment in Class B2 or C ward at public hospitals, then MediShield Life may be sufficient for you.

However, if you would like to receive more comprehensive hospitalisation coverage, you may wish to opt for an Integrated Shield Plan. Integrated Shield Plan enhances the basic coverage offered by MediShield Life by providing coverage for treatments for A/B1-type wards in public hospitals or at private hospitals. This allows you to seek treatment at private wards, and enjoy as-charged coverage for selected pre and post inpatient and outpatient treatments.


TLDR; Enhance your hospitalisation coverage with Integrated Shield Plan if you…

  • Would like to stay in private wards, and wish to choose your own doctor for treatment
  • Would like to increase your yearly claimable amount
  • Want as-charged coverage for selected pre and post inpatient and outpatient treatments

  • Changes to Integrated Shield Plan premiums

    In September 2022, the Life Insurance Association (LIA) announced that all seven Integrated Shield Plan providers will not change their premium rates for two years. However, this freeze on premiums is set to end on 31 August 2024. This means that you are likely tomay experience higher premiums at your next policy renewal.

    What we know – as of 23 August 2024:


    Premium adjustment for Enhanced IncomeShield, IncomeShield Standard Plan, IncomeShield, and all IncomeShield riders will take effect from 1 September 2024, upon renewal of the policy.
    Unspecified
    Premiums for Singlife Shield Plan 1 and Health Plus to be adjusted from 1 September 2024.

    No changes to premiums for Singlife Shield Plan 2, 3, Starter, and Standard Plan



    Affording your Integrated Shield Plan

    While the upcoming increase in premiums may be concerning, did you know that you could can potentially use MediSave to cover the cost of your integrated shield plan?

    Integrated Shield Plan enhances the basic coverage offered by MediShield Life and can be purchased from a private insurer. These plans are payable using MediSave up to the Additional Withdrawal Limits (AWLs). AWLs will differ by age, and any excess premiums will need to be paid in cash.

  • Additional Withdrawal Limits by age:

  • Age Next Birthday

    Additional Withdrawal Limits (AWLs)

    1 to 40
    $300
    41 to 70
    $600
    71 and above
    $900

    An illustration:

  • Enhanced IncomeShield or IncomeShield
  • As shown in the image below, individuals are able to use their AWLs to fully cover the premiums needed for Enhanced IncomeShield Preferred up to the age 40, or for Enhanced IncomeShield Basic up to the age of 75.

  • Raffles Shield
  • Alternatively, individuals who opt for Raffles Shield can use the AWLs to fully cover their premiums for Raffles Shield Private up till age 50, or for Raffles Shield B up to age 75.

  • Singlife Shield
  • Whereas for Singlife, individuals can enjoy $0 cash outlay for Singlife Shield Plan 1 up to age 30, or for Singlife Shield Plan 3 up to age 65.

    Integrated Shield Plans available on FSMOne:

  • Income - Enhanced IncomeShield
  • Raffles Health Insurance - Raffles Shield
  • Singlife - Singlife Shield
  • If you would like to enhance your coverage with Integrated Shield Plan, or would like to make changes to your plans to better utilise your Additional Withdrawal Limits, you may reach out to us here.

    However, if you already have your Integrated Shield Plan, you might like to consider iFAST Digital Term to complement your remaining protection needs. Available online on FSMOne, you can easily DIY your coverage in just a few minutes.


    Save more when you insure with FSMOne

    Enjoy up to 45% commission rebates when you apply through us

    Reach out to us for a complimentary insurance review





    Available Products on FSMOne Insurance

    Term Life, Whole Life, Critical Illness, Annuity, Health, Endowment, General Insurance (Personal and Commercial)


    from AIG, Allianz, Cigna, Chubb, Etiqa Insurance, FWD Insurance, Great Eastern, Henner, Income, Manulife, MSIG, Raffles Health Insurance, Singlife, Sompo, Tokio Marine, and QBE.


    *Please check with our team if the product you want is available on FSMOne Insurance



    You may also be interested in...

    Get this insurance with $0 cash outlay*

    What you need to know about the cost of cancer treatments and cancer plans

    Your TPD cover is not a disability insurance. Here’s why

    Are my Shield plans enough to cover me for cancer?



    Information obtained from:

    https://www.lia.org.sg/media/3554/lia-media-release-ip-support-for-policyholders.pdf

    https://www.income.com.sg/kcassets/2a30f5fc-c64d-4c30-8818-ca0ffaf93e98/Premium%20Table%20for%20Enhanced%20IncomeShield%20and%20IncomeShield%20Standard%20Plan.pdf

    https://www.raffleshealthinsurance.com/wp-content/uploads/2021/03/Raffles-Shield-Product-Summary-1-April-2024-Finalv1-1.pdf

    https://singlife.com/content/dam/public/sg/documents/medical-insurance/singlife-health-plus/Singlife-Shield-HealthPlus-PremiumRates.pdf

    Information retrieved on 23 August 2024.



    Disclaimer:

    All materials and content found in this article are strictly for information purposes only and should not be considered as an offer or solicitation to transact in any product.

    This article is not a contract of insurance. Insurance products are underwritten by the respective insurance partners and distributed by iFAST.

    Insurance products are underwritten by the respective insurance partners and distributed by iFAST Financial Pte Ltd (“iFAST”). You are advised to read the precise terms, conditions and exclusions specified in the relevant policy contract.

    This comparison does not include information on all similar products. iFAST does not guarantee that all aspects of the products have been illustrated. You may wish to conduct your own comparison for products that are listed in www.comparefirst.sg

    You are advised to read the key product documents, including (but not limited to) the product summary, before deciding whether the product is suitable for you. You should consider carefully if the products you are purchasing are suitable for your financial objectives, experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of a product, please seek advice from a financial adviser before making a decision to purchase the product.

    While iFAST and/or any of its third-party providers has/have tried to provide accurate and timely information, there may be inadvertent omissions, inaccuracies, and typographical errors. Opinions expressed herein are subjected to change without notice.

    More information on iFAST Digital Term can be found here.

    This advertisement has not been reviewed by the Monetary Authority of Singapore.

    All materials and contents found in this site are strictly for general circulation and informational purposes only and should not be considered as an offer, or solicitation, to deal in any of the funds or products found/identified in this site. While iFAST Financial Pte Ltd ("IFPL") has tried to provide accurate and timely information, there may be inadvertent delays, omissions, technical or factual inaccuracies and typographical errors. Any opinion or estimate contained in this report is made on a general basis and neither IFPL nor any of its servants or agents have given any consideration to nor have they or any of them made any investigation of the investment objective, financial situation or particular need of any user or reader, any specific person or group of persons. You should consider carefully if the products you are going to purchase are suitable for your investment objective, investment experience, risk tolerance and other personal circumstances. If you are uncertain about the suitability of the investment product, please seek advice from a financial adviser, before making a decision to purchase the investment product. Past performance is not indicative of future performance. The value of the investment products and the income from them may fall as well as rise. Opinions expressed herein are subject to change without notice. In respect of any matters arising from, or in connection with the said research analyses or research reports, recipients of the report are to contact IFPL at 10 Collyer Quay, #26-01 Ocean Financial Centre Building, Singapore 049315, or by telephone at +65 6557 2853. Where the report contains research analyses or research reports from a foreign research house and if the recipient of such research analyses or research reports is not an accredited investor, expert investor, institutional investor or an ex-accredited investor, IFPL accepts legal responsibility for the contents of such analyses or reports to such persons only to the extent as required by law. Please note that only certain security(ies) herein are available to all investors, while the rest are only available for certain persons to invest in, such as Accredited Investors (as defined in the Securities and Futures Act) or one who invests at least S$200,000 (or its equivalent currency) per transaction. To qualify as an Accredited Investor, one needs to submit a declaration form and certain relevant supporting documents, according to iFAST’s prevailing policies and procedures.

    Please read our full disclaimers on the website at ( https://secure.fundsupermart.com/fsmone/policies/328125/investment-account-terms-&-conditions).

    iFAST Financial Pte Ltd (IFPL) (registered address: 10 Collyer Quay #26-01 Ocean Financial Centre Singapore 049315, Telephone: 6557 2000) holds the Financial Advisers Licence issued by the Monetary Authority of Singapore ('MAS') to conduct regulated activities of advising on securities, marketing of collective investment schemes and arranging of any contract of insurance in respect of life policies, other than a contract of reinsurance and the Capital Markets Services Licence issued by the MAS to conduct regulated activities of dealing in securities and providing custodial services for securities. While IFPL has made every effort to ensure the independence of the report's contents, IFPL's nature of business is such that IFPL and its connected and associated entities together with their respective directors, officers and staff may be involved in providing dealing or investment-related services in the abovementioned securities, and have taken or may take positions in the securities mentioned in this report, and may also act as the principal for any buy or sell trades.